Table 2

Analysis of the echocardiograms of the patients before, during and after chemotherapy

Clinical characteristicsBefore chemotherapy (Embedded Imagē±s)During chemotherapy (Embedded Image±s)After chemotherapy (Embedded Image±s)F(B) or χ²P12P13P23
LVEF (%)64.458±3.71364.169±3.31463.992±3.6360.598(B)0.8960.7000.971
LAMAD (mm)31.508±3.48631.915±3.98831.966±4.1180.610(B)0.7890.7341.000
RAMD (mm)29.619±2.27629.644±2.56729.542±2.3950.945(B)1.0000.9920.985
LVEDD (mm)42.203±3.01442.115±3.34641.915±3.1070.773(B)0.9950.8510.951
LVESD (mm)26.822±2.79727.000±2.89727.195±2.5960.585(B)0.9500.6400.929
RVID (mm)14.627±1.64214.814±2.33515.093±3.3200.3630.5710.1580.396
  • P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.

  • LAMAD, left atrial maximum anteroposterior diameter; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; RAMD, right atrial mediolateral diameter; RVID, right ventricular internal dimension.